Skip to main content
    O

    Olema Pharmaceuticals Inc (OLMA)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $7.22
    -0.14 (-1.90%)

    Market Cap: $662.30M

    Last updated: Nov 17, 2026 at 4:15 PM ET

    Olema Pharmaceuticals Inc (OLMA) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Olema Pharmaceuticals (OLMA) has a market cap of $662.30M and an enterprise value of $617.78M. Revenue fell 100.00% over the last 12 months from the 12 months before. Its share count is up 17.92% from a year earlier.

    Total Valuation

    Enterprise value is 6.72% below the market cap, as cash exceeds debt.

    Market Cap$662.30M
    Enterprise Value$617.78M
    Latest price (Nov 17, 2026)$7.22

    Key Dates

    The next earnings report is expected on Mar 15, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateMar 15, 2027 (expected)
    Last Earnings DateNov 9, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count fell 3.22% in the quarter ended Sep 30, 2026 and grew 32.87% a year over 2 years.

    Shares Outstanding101.09M
    Shares Change (YoY)+17.92%
    Shares Change (QoQ)-3.22%
    Share Count Growth (2Y CAGR)+32.87%

    Price Statistics

    The stock is down 14.05% over 52 weeks and trades 10.20% below its 50-day average.

    Beta (1Y)1.43
    52-Week Change-14.05%
    1-Month Change+1.55%
    3-Month Change-36.16%
    6-Month Change-44.89%
    5-Year Change-74.07%
    Total Return (1Y)-14.05%
    Total Return (3Y CAGR)-23.15%
    Total Return (5Y CAGR)-21.96%
    Return vs SPY (1Y)-75.71%
    Max Drawdown (1Y)-82.11%
    Max Drawdown (3Y)-82.11%
    Sharpe Ratio (1Y)-1.42
    Correlation with SPY (1Y)0.27
    50-Day Average$8.04
    200-Day Average$12.90
    52-Week Range$6.24 to $36.26
    RSI (14 Days)46.1
    Average Volume (20 Days)1.48M

    The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 6.12x current liabilities, and total debt is 0.01x shareholder equity.

    Current Ratio6.12x
    Quick Ratio6.12x
    Debt / Equity0.01x

    Returns and Efficiency

    Return on invested capital is -53.81% over the last 12 months, against a 5-year average of -29.31%.

    Return on Equity (ROE)-63.97%
    Return on Assets (ROA)-53.49%
    Return on Invested Capital (ROIC)-53.81%
    ROE (5Y Average)-36.34%
    ROA (5Y Average)-33.34%
    ROIC (5Y Average)-29.31%

    Scores

    OLMA has a Piotroski F-Score of 1 of 9, in the weak band of 0 to 2.

    Piotroski F-Score1 of 9
    Piotroski StrengthWeak

    Income Statement

    Revenue was $0 over the last 12 months.

    Revenue$0
    Revenue Growth (YoY)-100.00%
    Gross Profit-$187.00K
    Operating Income-$252.77M
    Pretax Income-$235.95M
    Net Income-$235.95M
    Reported EPS (TTM)-$2.36

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 83.62% of the $441.07M in total assets.

    Cash and Equivalents$47.52M
    Total Debt$3.00M
    Net Cash$44.52M
    Net Cash Per Share$0.44
    Working Capital$354.19M
    Shareholder Equity$368.84M
    Book Value Per Share$3.65
    Total Assets$441.07M
    Total Liabilities$72.23M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    Operating Cash Flow-$177.32M
    FCF Per Share-$2.04
    Depreciation and Amortization$502.00K

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Growth

    Book Value Per Share Growth (2Y CAGR)+6.34%
    Tangible Book Per Share Growth (2Y CAGR)+6.34%

    Revenue and profit by year

    Dividends and Yields

    OLMA does not pay a dividend.

    Buyback Yield-4.98%
    Shareholder Yield-4.98%

    Peer Position

    Against 7 similar companies, OLMA has the 7th highest ROIC.

    ROIC-53.81% vs -14.91% median
    Revenue Growth (Trailing 4 Quarters, YoY)-100.00% vs -82.85% median

    Competitors compared

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Frequently Asked Questions About OLMA

    What is OLMA's market cap?

    Olema Pharmaceuticals has a market cap of $662.30M. Its enterprise value, which adds debt and subtracts cash, is $617.78M.

    How many shares of OLMA are outstanding?

    Olema Pharmaceuticals has 101.09M shares outstanding. The count is up 17.92% from a year earlier.

    Does OLMA pay a dividend?

    No. Olema Pharmaceuticals does not pay a dividend.

    How much debt does OLMA have?

    Olema Pharmaceuticals has $3.00M of total debt and $47.52M of cash and equivalents, a net cash position of $44.52M.